S.R.B. Heymans

Verdonschot, J. A. J., Van Spaendonck-Zwarts, K. Y., Hellebrekers, D. M. E., Asselbergs, F. W., Behr, E. R., Charron, P., Dawson, D., Garcia-Pavia, P., Haugaa, K. H., Jurcut, R., Kuchynka, P., Lopes, L. R., Mazzanti, A., Metra, M., Monserrat, L., Kaski, J. P., Pantazis, A., Prasad, S. K., Rosano, G., ... Van Tintelen, J. P. (2026). Genetic counselling implementation in dilated cardiomyopathy: A clinical consensus statement of the Heart Failure Association of the ESC, the ESC Working Group on Myocardial and Pericardial Diseases, and the ESC Council on Cardiovascular Genomics. European Heart Journal, 47(24), 3040-3051. https://doi.org/10.1093/eurheartj/ehag159

Heymans, S. (2026). The dual face of lamin A/C cardiomyopathy: risk prediction of heart failure and arrhythmias. European Heart Journal, 47(24), 3149-3151. https://doi.org/10.1093/eurheartj/ehag215

Bianchi, L., Afonso, L., Chendey, T., Modumudi, S., Minghini, A., Verdonschot, J. A. J., & Heymans, S. R. B. (2026). Efficacy and safety of sodium-glucose cotransporter inhibitors in hypertrophic cardiomyopathy: a systematic review. IJC Heart and Vasculature, 64, Article 101906. https://doi.org/10.1016/j.ijcha.2026.101906

Skouri, H., Abdin, A., Mullens, W., Bucciarelli Ducci, C., Starling, R. C., Van der Meer, P., Savarese, G., ben Gal, T., Bayes-Genis, A., Heymans, S., Klingel, K., Prasad, S. K., Farmakis, D., Chioncel, O., Ristic, A., Rosano, G., Seferovic, P., Ponikowiski, P., Metra, M., & Tschope, C. (2026). Evaluation and management of recent onset cardiomyopathy in the current era of heart failure therapeutics: a clinical consensus statement of the Heart Failure Association of the ESC. Esc heart failure, 13(3), Article xvag115. https://doi.org/10.1093/eschf/xvag115

Sikking, M. A., Peisker, F., Maatz, H., Lopez-Anguita, N., Hazebroek, M. R., Henkens, M. T. H. M., Raafs, A. G., Heymans, A. B. M., Stroeks, S. L. V. M., Abdul Hamid, M. A., Li, X., Vicenzetto, C., Caforio, A. L. P., Brunner-La Rocca, H.-P., Knackstedt, C., van Paassen, P., van Empel, V. P. M., Hubner, N., Verdonschot, J. A. J., & Heymans, S. R. B. (2026). Improved outcome up to 10 years after intravenous immunoglobulin therapy in patients with dilated cardiomyopathy. European journal of heart failure. Advance online publication. https://doi.org/10.1093/ejhf/xuag134

Baggio, C., Cannata, A., Gasperetti, A., Ammirati, E., Gentile, P., Peretto, G., Savonitto, G., Cecere, A., Collini, V., Sikking, M., Mistrulli, R., Pagannone, E., Rossi, V. A., Schmidt, D., Compagnucci, P., Casella, M., Artico, J., Ciabatti, M., Fabris, E., ... Marco, M. (2026). Insights Into the Natural History of Recurrent Myocarditis, A Multicenter International Study (Re-Myo Study). Journal of the American Heart Association, 15(10), Article e046767. https://doi.org/10.1161/JAHA.125.046767

de Gonzalo-Calvo, D., García-Hidalgo, M. C., Chatterjee, S., Thum, S., Ferreira, J. P., Rossignol, P., Girerd, N., Verdonschot, J. A. J., Heymans, S., Staessen, J. A., Cleland, J. G. F., Zannad, F., Thum, T., & Bär, C. (2026). Mechanistic insights into heart failure progression and therapeutic target discovery through plasma microRNA profiling: Findings from HOMAGE. European journal of internal medicine, 147, Article 106724. https://doi.org/10.1016/j.ejim.2026.106724

Deissler, P. M., Rahm, A. K., Berkovitch, A., Müller, M. E., Sikking, M., Heymans, S., Langenberg, B., Moersdorf, M., Rieder, M., Nimani, S., Odening, K. E., Dichtl, W., Sabbag, A., Volders, P. G. A., & Ter Bekke, R. M. A. (2026). Temporal variability of the electromechanical window in long-QT syndrome and drug-induced QT prolongation: Value for enhanced arrhythmia-risk assessment. Heart Rhythm, 23(4), e636-e646. https://doi.org/10.1016/j.hrthm.2026.01.013

Ravassa, S., Girerd, N., Edelman, F., Lopez, B., Ferreira, J. P., Zurkan, D., Jose, G. S., Latasa, I., Pellicori, P., Cosmi, F., Petutschnigg, J., Heymans, S., Brunner-La Rocca, H.-P., Pieske, B., Delles, C., Clark, A. L., Diez, J., Zannad, F., Cleland, J. G. F., ... HOMAGE Trial Committees and Investigators (2026). Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics. MedComm, 7(3), Article e70634. https://doi.org/10.1002/mco2.70634

Torfs, T., Veltrop, R. J. A., Lezzoche, G., Heymans, S. R. B., Verdonschot, J. A. J., & Nabben, M. (2026). Metabolic Dysregulation in Laminopathies: Implications for Heart Failure and Cardiac Health. Current Heart Failure Reports, 23(1), Article 6. https://doi.org/10.1007/s11897-025-00735-8